International patent of treating RSA (1)

The present invention relates to a medicament for treating recurrent spontaneous abortion, also called recurrent miscarriage. Invented  by  Chen Fenglin, director of Beijing Antai Hospital, this method obtained international patent with the number of 1719516, and the designated contracting states including: AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FIFR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR. 

Claim:

. A pharmaceutical compsition for treating a subject with recurrent spontaneous abortion characterized by comprising a therapeutically effective amount of chromosome No.2 derived from the spouse of said subject, characterized in that said chromosome No.2 is isolated from sometocytes in M phase.

2. A pharmaceutical compsition for treating a subject with recurrent spontaneous abortion characterized by comprising a therapeutically effective amount of chromosome No.2 derived from a plurality of males, characterized in that said chromosome No.2 is isolated from sometocytes in M phase.

3. The pharmaceutical composition according to claim 2, characterized in that the number of said plurality of males is more than 3, more than 10, or more than 20.

4. Chromosome No.2 derived from a male, for use in a method for treating of recurrent spontaneous aortion, characterized in that said chromosome No.2 is isolted from somatocytes in M phase.

5. Use of a substance capable of lowering the in vivo level of antinuclear antibody for the preparation of a medicament for treating recurrent spontaneous abortion, wherein said substance capable of lowering the in vivo level of antinuclear antibody is chromosome No.2 derived from a male, characterized in that said chromosome No.2 is isolated from somatocytes in M phase.

6. The use according to claim 5, wherein said substance capable of lowering the invivo level of antinuclear antibody is a mixture of chromosome No.2 derived from the spouse of the subject to be treated.

7. the use according to claim 5, wherein said substance capable of loering the invivo level of antinuclear antibody is a mixture of chromosome No.2 derived from a plurality of males.

8. The use according to claim 7, characterized in that the number of said plurality of males is more than 3, particularly more than 10, especially more than 20.